San Francisco, CA—Percutaneous closure of the patent ductus arteriosus (PDA) in children using a novel device is safe and effective, according to a prospective study presented in a featured clinical ...
Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...
The minimally invasive procedure involves placing a small catheter through a vein to deliver a tiny device that seals the PDA from within. The newly appointed chief of cardiovascular medicine and ...
MEMPHIS, Tenn., Feb. 7, 2019 /PRNewswire/ -- Le Bonheur Children's Hospital cardiologists have implanted the world's first commercially-approved medical device for transcatheter patent ductus ...
“This position statement represents a collective effort between neonatology, anesthesia, and interventional cardiology to provide comprehensive guidance on tcPDA device occlusion that can be adapted ...
New innovative capability brings lifesaving cardiac care directly to the NICU, reducing risks associated with transporting fragile premature infants. MIAMI , Sept. 22, 2025 /PRNewswire/ -- Nicklaus ...